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LETTERS TO THE EDITOR
Cord Blood Transplantation in a Child With Pearson’s Disease
To the Editor: We report the first case of successful CBT in a
molecular proved Pearson Disease (PD). The indication was
hematologic but the interesting finding is the correction of non
hematologic issues as metabolic acidosis and liver involvements.
The patient presented neonatal hypoglycemia, metabolic
acidosis, hyperlactacidemia and progressive pancytopenia treated
by GCSF (5 mg/Kg three times a week) and transfusions. He never
suffered from pancreatic insufficiency or neurologic disturbances
(MRI normal). Diagnosis of PD [1–4] was established by bone
marrow analysis (macrocytic sideroblastic anemia, ring sideroblasts
and hematopoietic precursor vacuolization) (Fig. 1) and liver
biopsy: mitochondrial respiratory enzymes measurements (spec-
trophotometry) revealed a combined deficiency of complexes I, III
and IV (mitochondrial complexes) with an increase in complex II
and in citrate synthetase (nuclear complexes). Mitochondrial DNA
studies performed on blood sample (Southern Blot Analysis)
detected deletion mutation (40% mutant mtDNA).
Clinical symptoms from age 2 years onward worsened and blood
products requirements increased; dysplasic features of red cells
and platelet precursors were observed. Chromosome 7 deletion—
del(7)(q22q32)—was detected in bone marrow until reaching 50%
of hematopoietic cells. Because of these myelodysplasic finding, an
unrelated cord blood transplantation (CBT) was performed at the
age of nearly 3 years. The conditionning regimen included busulfan
(37.5 mg/m2 days 8, 7, 6, 5), cyclophosphamide (60 mg/Kg days 4,
3) and Anti ThymoGlobulin (30 mg/Kg days 5, 4, 3). Hematopoietic
recovery was normal and no major complications occurred.
Three years after CBT the patient is doing well; hemogram is
normal with complete engraftment of all donor cell lineages.
Metabolic features of acidosis and lactacidemia as well as biological
hepatic abnormalities resolved. A liver biopsy was performed
showing resolution of morphological abnormalities; liver mito-
chondrial respiratory enzymes activities returned to normal range.
Deletions of chromosome 7 in PD have not yet been reported,
except after a double myeloablative therapy with reinfusion of
PBSC [5]. Our patient had a successful hematopoietic transplant
with correction of hematologic and non-hematologic features.
These observations suggest possible interactions between hema-
topoietic tissue and mitochondrial abnormalities. Our clinical
experience suggests hematopoietic transplantation is feasible in
PD and could be useful in management of other severe mtDNA
defect syndromes.
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Fig. 1. Bone marrow myeloid precursors showing cytoplasmic
vacuoles.
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